Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1
- PMID: 19479902
- DOI: 10.1002/jcb.22131
Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1
Abstract
Herein, we investigated the survival roles of Fak, Src, MEK/Erk, and PI3-K/Akt-1 in intestinal epithelial cancer cells (HCT116, HT29, and T84), in comparison to undifferentiated and differentiated intestinal epithelial cells (IECs). We report that: (1) cancer cells display striking anoikis resistance, as opposed to undifferentiated/differentiated IECs; (2) under anoikis conditions and consequent Fak down-activation, cancer cells nevertheless exhibit sustained Fak-Src interactions and Src/MEK/Erk activation, unlike undifferentiated/differentiated IECs; however, HCT116 and HT29 cells exhibit a PI3-K/Akt-1 down-activation, as undifferentiated/differentiated IECs, whereas T84 cells do not; (3) cancer cells require MEK/Erk for survival, as differentiated (but not undifferentiated) IECs; however, T84 cells do not require Fak and HCT116 cells do not require PI3-K/Akt-1, in contrast to the other cells studied; (4) Src acts as a cornerstone in Fak-mediated signaling to MEK/Erk and PI3-K/Akt-1 in T84 cells, as in undifferentiated IECs, whereas PI3-K/Akt-1 is Src-independent in HCT116, HT29 cells, as in differentiated IECs; and (5) EGFR activity inhibition abrogates anoikis resistance in cancer cells through a loss of Fak-Src interactions and down-activation of Src/MEK/Erk (T84, HCT116, HT29 cells) and PI3-K/Akt-1 (T84 cells). Hence, despite distinctions in signaling behavior not necessarily related to undifferentiated or differentiated IECs, intestinal epithelial cancer cells commonly display an EGFR-mediated sustained activation of Src under anoikis conditions. Furthermore, such sustained Src activation confers anoikis resistance at least in part through a consequent sustenance of Fak-Src interactions and MEK/Erk activation, thus not only overriding Fak-mediated signaling to MEK/Erk and/or PI3-K/Akt-1, but also the requirement of Fak and/or PI3-K/Akt-1 for survival.
2009 Wiley-Liss, Inc.
Similar articles
-
Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.J Cell Physiol. 2007 Sep;212(3):717-28. doi: 10.1002/jcp.21096. J Cell Physiol. 2007. PMID: 17443665
-
B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms.Apoptosis. 2008 Apr;13(4):531-42. doi: 10.1007/s10495-008-0192-y. Apoptosis. 2008. PMID: 18322799
-
Cell-cell contacts prevent anoikis in primary human colonic epithelial cells.Gastroenterology. 2007 Feb;132(2):587-600. doi: 10.1053/j.gastro.2006.11.017. Epub 2006 Nov 16. Gastroenterology. 2007. PMID: 17258732
-
The SRC-induced mesenchymal state in late-stage colon cancer cells.Cells Tissues Organs. 2005;179(1-2):73-80. doi: 10.1159/000084511. Cells Tissues Organs. 2005. PMID: 15942195 Review.
-
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer.Lancet Oncol. 2008 Mar;9(3):288-96. doi: 10.1016/S1470-2045(08)70073-1. Lancet Oncol. 2008. PMID: 18308254 Review.
Cited by
-
KRAS and BRAF mutations induce anoikis resistance and characteristic 3D phenotypes in Caco‑2 cells.Mol Med Rep. 2019 Nov;20(5):4634-4644. doi: 10.3892/mmr.2019.10693. Epub 2019 Sep 20. Mol Med Rep. 2019. PMID: 31545494 Free PMC article.
-
CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.PLoS One. 2014 Mar 17;9(3):e90159. doi: 10.1371/journal.pone.0090159. eCollection 2014. PLoS One. 2014. PMID: 24637722 Free PMC article.
-
RHBDL2 is a critical membrane protease for anoikis resistance in human malignant epithelial cells.ScientificWorldJournal. 2014;2014:902987. doi: 10.1155/2014/902987. Epub 2014 May 28. ScientificWorldJournal. 2014. PMID: 24977233 Free PMC article.
-
Live free or die: tales of homeless (cells) in cancer.Am J Pathol. 2010 Sep;177(3):1044-52. doi: 10.2353/ajpath.2010.091270. Epub 2010 Jul 16. Am J Pathol. 2010. PMID: 20639456 Free PMC article. Review.
-
Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation.J Signal Transduct. 2011;2011:738137. doi: 10.1155/2011/738137. Epub 2011 Jul 13. J Signal Transduct. 2011. PMID: 21785723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous